Seeking Alpha

Theravance (THRX +3.2%) and GlaxoSmithKline (GSK +0.1%) have submitted a regulatory application...

Theravance (THRX +3.2%) and GlaxoSmithKline (GSK +0.1%) have submitted a regulatory application to the E.U. for Anoro, an investigational combination medicine for patients with chronic obstructive pulmonary disease. The companies submitted a regulatory application in the U.S. for the drug last December.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|